Home > Pharmaceuticals and Healthcare > Digital Genome Market Size By Product (Sequencing & Analyzer Instruments, DNA/RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software, Sam...

Digital Genome Market Size By Product (Sequencing & Analyzer Instruments, DNA/RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software, Sample Prep Instruments), By Application (Microbiology [Biological, Clinical, Industrial], Reproductive & Genetic, Transplantation, Livestock and Agriculture, Forensics, Research and Development), By End-Use (Diagnostics & Forensic Labs, Academic Research Institutes, Hospitals, Bio-pharmaceutical Companies), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Italy, Spain, Russia, France, China, Japan, India, Australia, Argentina, Brazil, Mexico South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 - 2024

No. of Pages: 150No. of Tables & Figures: 103Published : 17 Mar 2017

Request Sample
 

Digital Genome Market size is set to exceed USD 45 billion by 2024; as per a new research report. Increased adoption of personalized medicine aimed at identifying genomic markers of disease and prescribe drugs that specifically target the pathway will drive the digital genome market size. Growing emphasis on sensitivity and specificity of the gene sequencing instruments should also fuel industry growth. In 2015, sequencing and analyzing instruments accounted for over 40% of digital genome market share. Technological innovation for development of novel instruments coupled with growing investments in genetic research will provide thrust to industry expansion. Sequencing chips should witness over 10% CAGR owing to continuous R&D in bioinformatics, microfluidics, enzymology, and nanotechnology providing innovative platforms for digital genome market growth. Biotechnology innovation has enabled development of genetically modified organisms (GMOs) in order to introduce specific improvements or traits. Successful production and commercialization of such modified organisms should stimulate business growth. Extensive applications in clinical diagnosis and research will also contribute to industry growth. Effective disease management strategies for chronic ailments and growing number of private and public investments and grants are forecast to propel digital genome market growth over the forecast years. Concerns pertaining to security and confidentiality of patient data, lack of experienced professional and complex return on investment structure may hamper the digital genome market growth. Increasing application of digital genomics in next generation sequencing and wide use of microbes in diagnostics industry will stimulate microbiology segment growth; the segment is anticipated to surpass USD 10 billion by 2024. Bio-pharmaceutical companies accounted for over 45% of digital genome market share due to increasing demand for targeted drug therapy. Growing usage trend for precision medicines should provide lucrative growth opportunities for segment growth. U.S. digital genome market size accounted for over 80% of the North American revenue in 2015, mainly due to the presence of established healthcare infrastructure and advanced facilities for effective treatment and care. The successful completion of Human Genome Project (HGP) has attracted significant public and private initiatives, driving the business growth. In 2015, Germany digital genome market size was valued at over USD 1.4 billion and is anticipated to witness considerable growth till 2024. Increasing investments by public and private companies for development of novel technologies should boost digital genome industry growth. China digital genome market is set to witness over 10% CAGR owing to favorable government initiative for development of human genetic resources platform and increasing collaboration among research institutes for creation of genomic databases and biobanks. Some of the players operating in this industry include Perkin Elmer, Qiagen, Illumina, Becton Dickinson, Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, Veracyte, Trovagene, Affymetrix and Neogen. The industry participants are investing heavily in R&D to develop innovative products which would provide competitive advantage. Some of the major players in sequencing and analysis instruments market include Life Technologies, Illumina, Thermo Fisher Scientific, and Roche. Few of the advanced sequencing technologies are Illumina (Solexa) sequencing, Roche 454 sequencing, Ion torrent: proton/ PGM sequencing and SOLiD (sequencing by Oligonucleotide Ligation and Detection) sequencing. Digital genome market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2012 to 2024, for the following segments: Digital Genome Market By Product Sequencing & Analyzer Instruments DNA/RNA Analysis Kits Sequencing Chips Sequencing & Analysis Software Sample Prep Instruments Digital Genome Market By Application Microbiology Biological Clinical Industrial Reproductive & Genetic Transplantation Livestock and Agriculture Forensics Research and Development Digital Genome Market By End-Use Diagnostics & Forensic Labs Academic Research Institutes Hospitals Bio-pharmaceutical companies The above information is provided on a regional and country basis for the following: North America U.S. Canada Europe Germany UK Italy France Spain Russia Latin America (LATAM) Argentina Brazil Mexico Asia Pacific China Japan India Australia Middle East South Africa Saudi Arabia

 

Report Content

Chapter 1. Methodology and Scope

1.1. Methodology

1.1.1. Initial data exploration

1.1.2. Statistical model & forecast

1.1.3. Industry insights & validation

1.1.4. Scope, definitions & research assumptions

1.2. Data Sources

1.2.1. Primary

1.2.2. Secondary

Chapter 2. Executive Summary

2.1. Digital Genome industry 360 degree synopsis, 2012 - 2024 (USD Million)

2.1.1. Business trends

2.1.2. Product trends

2.1.3. Application trends

2.1.4. End-use trends

2.1.5. Regional trends

Chapter 3. Digital Genome Industry Insights

3.1. Industry segmentation

3.2. Industry size and forecast, 2012 - 2024 (USD Million)

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Successful completion of the Human Genome Project

3.3.1.2. Increasing public-private investments, funds, and grants

3.3.1.3. Advances in biotechnology

3.3.1.4. Increased Application in clinical diagnosis

3.3.1.5. Rising use of personalized medicine

3.3.1.6. Rise in incidence and prevalence of chronic diseases

3.3.1.7. Reduced cost and high speed for DNA sequencing

3.3.2. Industry pitfalls & challenges

3.3.2.1. Unclear ROI of precision medicine

3.3.2.2. Lack of trained staff

3.4. Growth potential analysis

3.5. Porter’s analysis

3.6. Technology landscape

3.6.1. Advent of novel technologies

3.7. Company market share analysis, 2015

3.7.1. Strategy dashboard

3.8. PESTEL analysis

Chapter 4. Digital Genome Market, By Product

4.1. Digital genome market share by product, 2015 & 2024

4.2. Sequencing & Analyzer Instruments

4.2.1.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

4.3. DNA/RNA Analysis Kits

4.3.1.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

4.4. Sequencing Chips

4.4.1.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

4.5. Sequencing & Analysis Software

4.5.1.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

4.6. Sample Prep Instruments

4.6.1.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

Chapter 5. Digital Genome Market, By Application

5.1. Digital genome market share by application, 2015 & 2024

5.2. Microbiology

5.2.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

5.2.2. Biological

5.2.2.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

5.2.3. Clinical

5.2.3.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

5.2.4. Industrial

5.2.4.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

5.3. Reproductive & Genetic

5.3.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

5.4. Transplantation

5.4.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

5.5. Livestock and Agriculture

5.5.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

5.6. Forensics

5.6.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

5.7. Research and Development

5.7.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

Chapter 6. Digital Genome Market, By End-use

6.1. Digital genome market share by End-use, 2015 & 2024

6.2. Diagnostics & Forensic Labs

6.2.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

6.3. Academic Research Institutes

6.3.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

6.4. Hospitals

6.4.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

6.5. Bio-pharmaceutical companies

6.5.1. Market estimates and forecast, by region, 2012 - 2024 (USD Million)

Chapter 7. Digital Genome Market, By Region

7.1. Digital genome market share by region, 2015 & 2024

7.2. North America

7.2.1. Market estimates and forecast, by country, 2012 - 2024 (USD Million)

7.2.2. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.2.3. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.2.4. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.2.5. U.S.

7.2.5.1. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.2.5.2. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.2.5.3. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.2.6. Canada

7.2.6.1. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.2.6.2. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.2.6.3. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.3. Europe

7.3.1. Market estimates and forecast, by country, 2012 - 2024 (USD Million)

7.3.2. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.3.3. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.3.4. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.3.5. Germany

7.3.5.1. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.3.5.2. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.3.5.3. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.3.6. UK

7.3.6.1. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.3.6.2. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.3.6.3. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.3.7. Italy

7.3.7.1. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.3.7.2. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.3.7.3. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.3.8. France

7.3.8.1. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.3.8.2. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.3.8.3. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.3.9. Spain

7.3.9.1. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.3.9.2. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.3.9.3. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.3.10. Russia

7.3.10.1. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.3.10.2. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.3.10.3. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.4. Asia Pacific

7.4.1. Market estimates and forecast, by country, 2012 - 2024 (USD Million)

7.4.2. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.4.3. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.4.4. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.4.5. China

7.4.5.1. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.4.5.2. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.4.5.3. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.4.6. Japan

7.4.6.1. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.4.6.2. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.4.6.3. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.4.7. India

7.4.7.1. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.4.7.2. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.4.7.3. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.4.8. Australia

7.4.8.1. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.4.8.2. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.4.8.3. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.5. Latin America

7.5.1. Market estimates and forecast, by country, 2012 - 2024 (USD Million)

7.5.2. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.5.3. Market estimates and forecast, by Application, 2012 - 2024 (USD Million)

7.5.4. Market estimates and forecast, by End-use, 2012 - 2024 (USD Million)

7.5.5. Argentina

7.5.5.1. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.5.5.2. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.5.5.3. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.5.6. Brazil

7.5.6.1. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.5.6.2. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.5.6.3. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.5.7. Mexico

7.5.7.1. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.5.7.2. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.5.7.3. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.6. Middle East and Africa

7.6.1. Market estimates and forecast, by country, 2012 - 2024 (USD Million)

7.6.2. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.6.3. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.6.4. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.6.5. South Africa

7.6.5.1. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.6.5.2. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.6.5.3. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

7.6.6. Saudi Arabia

7.6.6.1. Market estimates and forecast, by product, 2012 - 2024 (USD Million)

7.6.6.2. Market estimates and forecast, by application, 2012 - 2024 (USD Million)

7.6.6.3. Market estimates and forecast, by end-use, 2012 - 2024 (USD Million)

Chapter 8. Company Profiles

8.1. Thermo Fisher

8.1.1. Business Overview

8.1.2. Financial Data

8.1.3. Industry Landscape

8.1.4. Strategic Outlook

8.2. Perkin Elmer

8.2.1. Business Overview

8.2.2. Financial Data

8.2.3. Industry Landscape

8.2.4. Strategic Outlook

8.3. Qiagen

8.3.1. Business Overview

8.3.2. Financial Data

8.3.3. Industry Landscape

8.3.4. Strategic Outlook

8.4. Illumina

8.4.1. Business Overview

8.4.2. Financial Data

8.4.3. Industry Landscape

8.4.4. Strategic Outlook

8.5. Becton Dickinson

8.5.1. Business Overview

8.5.2. Financial Data

8.5.3. Industry Landscape

8.5.4. Strategic Outlook

8.6. Agilent

8.6.1. Business Overview

8.6.2. Financial Data

8.6.3. Industry Landscape

8.6.4. Strategic Outlook

8.7. Sigma Aldrich

8.7.1. Business Overview

8.7.2. Financial Data

8.7.3. Industry Landscape

8.7.4. Strategic Outlook

8.8. Fluidigm

8.8.1. Business Overview

8.8.2. Financial Data

8.8.3. Industry Landscape

8.8.4. Strategic Outlook

8.9. Pacific Biosciences

8.9.1. Business Overview

8.9.2. Financial Data

8.9.3. Industry Landscape

8.9.4. Strategic Outlook

8.10. F. Hoffmann-La Roche

8.10.1. Business Overview

8.10.2. Financial Data

8.10.3. Industry Landscape

8.10.4. Strategic Outlook

8.11. Agios

8.11.1. Business Overview

8.11.2. Financial Data

8.11.3. Industry Landscape

8.11.4. Strategic Outlook

8.12. AVEO Oncology

8.12.1. Business Overview

8.12.2. Financial Data

8.12.3. Industry Landscape

8.12.4. Strategic Outlook

8.13. Biomarin

8.13.1. Business Overview

8.13.2. Financial Data

8.13.3. Industry Landscape

8.13.4. Strategic Outlook

8.14. BioReference

8.14.1. Business Overview

8.14.2. Financial Data

8.14.3. Industry Landscape

8.14.4. Strategic Outlook

8.15. Cancer Genetics

8.15.1. Business Overview

8.15.2. Financial Data

8.15.3. Industry Landscape

8.15.4. Strategic Outlook

8.16. Clovis Oncology

8.16.1. Business Overview

8.16.2. Financial Data

8.16.3. Industry Landscape

8.16.4. Strategic Outlook

8.17. CombiMatrix

8.17.1. Business Overview

8.17.2. Financial Data

8.17.3. Industry Landscape

8.17.4. Strategic Outlook

8.18. Foundation Medicine

8.18.1. Business Overview

8.18.2. Financial Data

8.18.3. Industry Landscape

8.18.4. Strategic Outlook

8.19. Genomic Health

8.19.1. Business Overview

8.19.2. Financial Data

8.19.3. Industry Landscape

8.19.4. Strategic Outlook

8.20. MacroGen (Korea)

8.20.1. Business Overview

8.20.2. Financial Data

8.20.3. Industry Landscape

8.20.4. Strategic Outlook

8.21. LabCorp

8.21.1. Business Overview

8.21.2. Financial Data

8.21.3. Industry Landscape

8.21.4. Strategic Outlook

8.22. NanoString Technologies

8.22.1. Business Overview

8.22.2. Financial Data

8.22.3. Industry Landscape

8.22.4. Strategic Outlook

8.23. Quest

8.23.1. Business Overview

8.23.2. Financial Data

8.23.3. Industry Landscape

8.23.4. Strategic Outlook

8.24. Regeneron

8.24.1. Business Overview

8.24.2. Financial Data

8.24.3. Industry Landscape

8.24.4. Strategic Outlook

8.25. Rosetta Genomics

8.25.1. Business Overview

8.25.2. Financial Data

8.25.3. Industry Landscape

8.25.4. Strategic Outlook

8.26. Sequenom

8.26.1. Business Overview

8.26.2. Financial Data

8.26.3. Industry Landscape

8.26.4. Strategic Outlook

8.27. Tesaro

8.27.1. Business Overview

8.27.2. Financial Data

8.27.3. Industry Landscape

8.27.4. Strategic Outlook

8.28. Veracyte

8.28.1. Business Overview

8.28.2. Financial Data

8.28.3. Industry Landscape

8.28.4. Strategic Outlook

8.29. Trovagene

8.29.1. Business Overview

8.29.2. Financial Data

8.29.3. Industry Landscape

8.29.4. Strategic Outlook

8.30. BGI (China)

8.30.1. Business Overview

8.30.2. Financial Data

8.30.3. Industry Landscape

8.30.4. Strategic Outlook

8.31. Affymetrix

8.31.1. Business Overview

8.31.2. Financial Data

8.31.3. Industry Landscape

8.31.4. Strategic Outlook

8.32. Neogen

8.32.1. Business Overview

8.32.2. Financial Data

8.32.3. Industry Landscape

8.32.4. Strategic Outlook

8.33. Zoetis

8.33.1. Business Overview

8.33.2. Financial Data

8.33.3. Industry Landscape

8.33.4. Strategic Outlook

8.34. bioMerieux

8.34.1. Business Overview

8.34.2. Financial Data

8.34.3. Industry Landscape

8.34.4. Strategic Outlook

8.35. Cepheid

8.35.1. Business Overview

8.35.2. Financial Data

8.35.3. Industry Landscape

8.35.4. Strategic Outlook

8.36. GenMark Diagnostics

8.36.1. Business Overview

8.36.2. Financial Data

8.36.3. Industry Landscape

8.36.4. Strategic Outlook

8.37. Nanosphere

8.37.1. Business Overview

8.37.2. Financial Data

8.37.3. Industry Landscape

8.37.4. Strategic Outlook

8.38. General Electric

8.38.1. Business Overview

8.38.2. Financial Data

8.38.3. Industry Landscape

8.38.4. Strategic Outlook

8.39. Quintiles

8.39.1. Business Overview

8.39.2. Financial Data

8.39.3. Industry Landscape

8.39.4. Strategic Outlook

8.40. 23andMe

8.40.1. Business Overview

8.40.2. Financial Data

8.40.3. Industry Landscape

8.40.4. Strategic Outlook

8.41. Counsyl

8.41.1. Business Overview

8.41.2. Financial Data

8.41.3. Industry Landscape

8.41.4. Strategic Outlook

8.42. Ancestry

8.42.1. Business Overview

8.42.2. Financial Data

8.42.3. Industry Landscape

8.42.4. Strategic Outlook



Data Tables

TABLE 1 Digital genome industry 360 degree synopsis, 2012 - 2024

TABLE 2 Global Digital genome market, by product, 2012 - 2024 (USD Million)

TABLE 3 Global Digital genome market, by Sequencing & Analyzer Instruments, 2012 - 2024 (USD Million)

TABLE 4 Global Digital genome market, by DNA/RNA Analysis Kits, 2012 - 2024 (USD Million)

TABLE 5 Global Digital genome market, by Sequencing Chips, 2012 - 2024 (USD Million)

TABLE 6 Global Digital genome market, by Sequencing & Analysis Software, 2012 - 2024 (USD Million)

TABLE 7 Global Digital genome market, by Sample Prep Instruments, 2012 - 2024 (USD Million)

TABLE 8 Global Digital genome market, by application, 2012 - 2024 (USD Million)

TABLE 9 Global Digital genome market, by Microbiology, 2012 - 2024 (USD Million)

TABLE 10 Global Digital genome market, by Biological, 2012 - 2024 (USD Million)

TABLE 11 Global Digital genome market, by Clinical, 2012 - 2024 (USD Million)

TABLE 12 Global Digital genome market, by Industrial, 2012 - 2024 (USD Million)

TABLE 13 Global Digital genome market, by Reproductive & Genetic, 2012 - 2024 (USD Million)

TABLE 14 Global Digital genome market, by app Transplantation, 2012 - 2024 (USD Million)

TABLE 15 Global Digital genome market, by Livestock and Agriculture, 2012 - 2024 (USD Million)

TABLE 16 Global Digital genome market, by Forensics, 2012 - 2024 (USD Million)

TABLE 17 Global Digital genome market, by Research and Development, 2012 - 2024 (USD Million)

TABLE 18 Global Digital genome market, by End-use, 2012 - 2024 (USD Million)

TABLE 19 Global Digital genome market, by Diagnostics & Forensic Labs, 2012 - 2024 (USD Million)

TABLE 20 Global Digital genome market, by Academic Research Institutes, 2012 - 2024 (USD Million)

TABLE 21 Global Digital genome market, by Hospitals, 2012 - 2024 (USD Million)

TABLE 22 Global Digital genome market, by Bio-pharmaceutical Companies, 2012 - 2024 (USD Million)

TABLE 23 Global Digital genome market, by region, 2012 - 2024 (USD Million)

TABLE 24 Growth drivers

TABLE 25 Industry pitfalls & challenges

TABLE 26 North America market, by country, 2012 - 2024 (USD Million)

TABLE 27 North America market, by product, 2012 - 2024 (USD Million)

TABLE 28 North America market, by application, 2012 - 2024 (USD Million)

TABLE 29 North America market, by end-use, 2012 - 2024 (USD Million)

TABLE 30 U.S. market, by product, 2012 - 2024 (USD Million)

TABLE 31 U.S. market, by application, 2012 - 2024 (USD Million)

TABLE 32 U.S. market, by end-use, 2012 - 2024 (USD Million)

TABLE 33 Canada market, by product, 2012 - 2024 (USD Million)

TABLE 34 Canada market, by application, 2012 - 2024 (USD Million)

TABLE 35 Canada market, by end-use, 2012 - 2024 (USD Million)

TABLE 36 Europe market, by country, 2012 - 2024 (USD Million)

TABLE 37 Europe market, by product, 2012 - 2024 (USD Million)

TABLE 38 Europe market, by application, 2012 - 2024 (USD Million)

TABLE 39 Europe market, by end-use, 2012 - 2024 (USD Million)

TABLE 40 Germany market, by product, 2012 - 2024 (USD Million)

TABLE 41 Germany market, by application, 2012 - 2024 (USD Million)

TABLE 42 Germany market, by end-use, 2012 - 2024 (USD Million)

TABLE 43 UK market, by product, 2012 - 2024 (USD Million)

TABLE 44 UK market, by application, 2012 - 2024 (USD Million)

TABLE 45 UK market, by end-use, 2012 - 2024 (USD Million)

TABLE 46 Italy market, by product, 2012 - 2024 (USD Million)

TABLE 47 Italy market, by application, 2012 - 2024 (USD Million)

TABLE 48 Italy market, by end-use, 2012 - 2024 (USD Million)

TABLE 49 France market, by product, 2012 - 2024 (USD Million)

TABLE 50 France market, by application, 2012 - 2024 (USD Million)

TABLE 51 France market, by end-use, 2012 - 2024 (USD Million)

TABLE 52 Spain market, by product, 2012 - 2024 (USD Million)

TABLE 53 Spain market, by application, 2012 - 2024 (USD Million)

TABLE 54 Spain market, by end-use, 2012 - 2024 (USD Million)

TABLE 55 Russia market, by product, 2012 - 2024 (USD Million)

TABLE 56 Russia market, by application, 2012 - 2024 (USD Million)

TABLE 57 Russia market, by end-use, 2012 - 2024 (USD Million)

TABLE 58 Asia Pacific market, by country, 2012 - 2024 (USD Million)

TABLE 59 Asia Pacific market, by product, 2012 - 2024 (USD Million)

TABLE 60 Asia Pacific market, by application, 2012 - 2024 (USD Million)

TABLE 61 Asia Pacific market, by end-use, 2012 - 2024 (USD Million)

TABLE 62 China market, by product, 2012 - 2024 (USD Million)

TABLE 63 China market, by application, 2012 - 2024 (USD Million)

TABLE 64 China market, by end-use, 2012 - 2024 (USD Million)

TABLE 65 Japan market, by product, 2012 - 2024 (USD Million)

TABLE 66 Japan market, by application, 2012 - 2024 (USD Million)

TABLE 67 Japan market, by end-use, 2012 - 2024 (USD Million)

TABLE 68 India market, by product, 2012 - 2024 (USD Million)

TABLE 69 India market, by application, 2012 - 2024 (USD Million)

TABLE 70 India market, by end-use, 2012 - 2024 (USD Million)

TABLE 71 Australia market, by product, 2012 - 2024 (USD Million)

TABLE 72 Australia market, by application, 2012 - 2024 (USD Million)

TABLE 73 Australia market, by end-use, 2012 - 2024 (USD Million)

TABLE 74 Latin America market, by product, 2012 - 2024 (USD Million)

TABLE 75 Latin America market, by application, 2012 - 2024 (USD Million)

TABLE 76 Latin America market, by end-use, 2012 - 2024 (USD Million)

TABLE 77 Argentina market, by product, 2012 - 2024 (USD Million)

TABLE 78 Argentina market, by application, 2012 - 2024 (USD Million)

TABLE 79 Argentina market, by end-use, 2012 - 2024 (USD Million)

TABLE 80 Brazil market, by product, 2012 - 2024 (USD Million)

TABLE 81 Brazil market, by application, 2012 - 2024 (USD Million)

TABLE 82 Brazil market, by end-use, 2012 - 2024 (USD Million)

TABLE 83 Mexico market, by product, 2012 - 2024 (USD Million)

TABLE 84 Mexico market, by application, 2012 - 2024 (USD Million)

TABLE 85 Mexico market, by end-use, 2012 - 2024 (USD Million)

TABLE 86 MEA market, by country, 2012 - 2024 (USD Million)

TABLE 87 MEA market, by product, 2012 - 2024 (USD Million)

TABLE 88 MEA market, by application, 2012 - 2024 (USD Million)

TABLE 89 MEA market, by end-use, 2012 - 2024 (USD Million)

TABLE 90 South Africa market, by product, 2012 - 2024 (USD Million)

TABLE 91 South Africa market, by application, 2012 - 2024 (USD Million)

TABLE 92 South Africa market, by end-use, 2012 - 2024 (USD Million)

TABLE 93 Saudi Arabia market, by product, 2012 - 2024 (USD Million)

TABLE 94 Saudi Arabia market, by application, 2012 - 2024 (USD Million)

TABLE 95 Saudi Arabia market, by end-use, 2012 - 2024 (USD Million)

Charts & Figures

FIG. 1 Industry segmentation

FIG. 2 Global digital genome market, 2012 - 2024 (USD Million)

FIG. 3 Industry ecosystem analysis

FIG. 4 Industry impact forces

FIG. 5 Growth potential analysis

FIG. 6 Digital genome company market share analysis, 2015

FIG. 7 Porter’s analysis

FIG. 8 PESTEL analysis

Each publisher of market research reports has a unique methodology. The differentiating factors keep them competitive and lend a proprietary touch to their research. By working with multiple publishers, MarketSizeForecasters.com aims to offer a centralized research library to our website visitors and clients. Coming soon, this section will display the research methodology of concerned publisher with an objective to help you take an informed decision. Till then, feel free to contact us via the form below to get your questions on methodology answered:


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Report ID : MSF45387

Publisher Name : Global Market Insights, Inc.

Why Market Size Forecasters?

  • Reports at Lowest Prices - Guaranteed
  • Fastest Growing Research Reports’ Database
  • Easy Customization Options
  • 24 X 7 Support Commitment
  • Certified, Safe & Secured Payments

Have A Question?

Ask UsView FAQ's